Artificial T-Cell Receptors NewsLatest News On Artificial T-Cell Receptors Promise for CAR T-Cell Therapies in Solid Tumors?2/10/2025 6:36 AM Cellular Therapies for Solid Tumors: The Next Big Thing?12/23/2024 2:49 PM CAR-T Cells and Beyond: Breakthroughs and Challenges Ahead12/16/2024 6:25 AM Early Success Seen With CAR T-Cell Therapy for Systemic Sclerosis12/13/2024 6:16 AM Epcore NHL-1 Update: Treatment Effective Before CAR T12/9/2024 12:43 AM Can New Therapies Redefine Psoriasis Management?11/27/2024 5:11 AM ASH 2024 Myeloma Studies: My Top 10 Picks11/27/2024 1:48 AM FDA Approved Obe-cel, a Novel CD19 CAR T Product for ALL11/8/2024 4:54 PM ACR Convergence 2024 Preview: What You Need to Know11/7/2024 3:48 AM Outpatient CAR T: Safe, Effective, Accessible11/1/2024 7:22 AM Multi-Refractory MM: After Immunotherapy, What?10/25/2024 7:49 AM Lymphoma Debate: CAR T Not a Clear Winner10/24/2024 9:09 AM First-in-Class B-Cell Depleting Agent Promising for Myasthenia Gravis10/17/2024 5:12 AM Many Hurdles Exist to Treating Lung Cancer With CAR T Cells10/10/2024 7:41 AM CARTITUDE-4 Update: Cilta-Cel Improves OS in R/R MM10/3/2024 6:30 AM 'Encouraging' Early Data for mRNA Vaccine in Glioblastoma9/13/2024 1:38 PM Treatment Options in MCL: What Are the Best Practices?9/12/2024 10:25 AM FDA Approves First Engineered Cell Therapy for a Solid Tumor8/2/2024 12:16 PM LBCL: CAR T Benefits Both Young and Old7/30/2024 1:07 AM Expanding Data Pool for CAR T-Cell Treatment Demonstrates Consistent Efficacy Across Refractory Rheumatic Diseases7/8/2024 5:28 AM
